Berna Bozkurt Duman

Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study

Meral Günaldı, Berna Bozkurt Duman, Çiğdem Usul Afşar et al. · Journal of Oncology Pharmacy Practice · 2015 · 50 citations

Factors Affecting the Tuberculosis Risk in Patients Receiving Anti-Tumor Necrosis Factor-α Treatment

Şermin Börekçi, Ersan Atahan, Deniz Demir Yılmaz et al. · Respiration · 2015 · 38 citations · Full text

Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study

Kadir Eser, Arif Hakan Önder, Emel Sezer et al. · BMC Cancer · 2022 · 33 citations · Full text

PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma

Vehbi Erçolak, Semra Paydaş, Melek Ergin et al. · Acta Haematologica · 2015 · 23 citations

PTEN, Akt, MAPK, p53 and p95 expression to predict trastuzumab resistance in HER2 positive breast cancer.

Berna Bozkurt Duman, B. Şahin, Melek Ergin et al. · 福建农业 · 2013 · 21 citations